GTC Biotherapeutics (fka GTCB)

[MTB]

It seems a great thought Keitern.

While my understanding on this topic is limited at present, I'd imagine that the difficulties with ATIII of IV dosing and non-specific activity for most non-emergent/hospital-based needs for anti-inflammatories would be limitations, but if our goat-produced alpha feto-protein fails in its trials for RA/uveitis, we can throw them ATIII!

Best,
MTB